Recombinant activated factor VII in cardiac surgery - first, do no harm.
作者信息
Warren Oliver J, Darzi Ara W, Athanasiou Thanos
出版信息
J Cardiothorac Surg. 2007 Nov 24;2:50. doi: 10.1186/1749-8090-2-50.
Abstract
摘要
相似文献
1
Recombinant activated factor VII in cardiac surgery - first, do no harm.心脏手术中重组活化凝血因子VII——首先，切勿造成伤害。
J Cardiothorac Surg. 2007 Nov 24;2:50. doi: 10.1186/1749-8090-2-50.
2
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.诺其®用于心脏手术出血后的凝血变化。
Asian Cardiovasc Thorac Ann. 2017 Feb;25(2):99-104. doi: 10.1177/0218492317689901. Epub 2017 Jan 23.
3
Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
Ann Thorac Surg. 2005 Jul;80(1):3-5. doi: 10.1016/j.athoracsur.2005.04.007.
4
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.应用重组活化因子 VII 控制体外循环下心内直视手术后难治性出血
J Cardiothorac Vasc Anesth. 2011 Dec;25(6):987-94. doi: 10.1053/j.jvca.2011.05.012. Epub 2011 Aug 11.
5
Recombinant activated factor VII in cardiac surgery: single-center experience.重组活化凝血因子 VII 在心脏手术中的应用：单中心经验
Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):148-54. doi: 10.1177/0218492312471672. Epub 2013 Jul 16.
6
The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.用大锤砸坚果的危险：旋转血栓弹力图（ROTEM）指导下对一名心室辅助装置植入术后难治性出血患者使用重组活化凝血因子VII。
Artif Organs. 2015 Mar;39(3):248-53. doi: 10.1111/aor.12355. Epub 2014 Jul 28.
7
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.重症监护病房复杂心血管手术后重组活化因子 VII 的给药：临床和经济结局。
J Thorac Cardiovasc Surg. 2011 Jun;141(6):1469-77.e2. doi: 10.1016/j.jtcvs.2011.02.033. Epub 2011 Mar 31.
8
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):574-5; author reply 575-6. doi: 10.1056/NEJMc1013591.
9
Safety of recombinant activated factor VII in randomized clinical trials.重组活化凝血因子VII在随机临床试验中的安全性。
N Engl J Med. 2011 Feb 10;364(6):574; author reply 575-6. doi: 10.1056/NEJMc1013591.
10
Off-label use of recombinant activated factor VII--safe or not safe?重组活化凝血因子 VII 的非标签使用——安全与否？
N Engl J Med. 2010 Nov 4;363(19):1853-4. doi: 10.1056/NEJMe1008857.
本文引用的文献
1
Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: case report and review of the current literature.心室辅助装置患者应用重组活化凝血因子VII（诺其）：病例报告及当前文献综述
J Cardiothorac Surg. 2007 Oct 26;2:47. doi: 10.1186/1749-8090-2-47.
2
Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.心脏手术围手术期输血与血液保护：胸外科医师协会和心血管麻醉医师协会临床实践指南
Ann Thorac Surg. 2007 May;83(5 Suppl):S27-86. doi: 10.1016/j.athoracsur.2007.02.099.
3
Recombinant activated factor VII in cardiac surgery: a systematic review.心脏手术中重组活化凝血因子 VII：一项系统评价
Ann Thorac Surg. 2007 Feb;83(2):707-14. doi: 10.1016/j.athoracsur.2006.10.033.
4
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.重组凝血因子VIIa用于抗凝治疗、肝硬化或严重创伤性损伤继发凝血病患者：安全性概况综述
Transfusion. 2006 Jun;46(6):919-33. doi: 10.1111/j.1537-2995.2006.00824.x.
5
Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation.人类多形核白细胞在受到刺激后会产生并表达功能性组织因子。
J Thromb Haemost. 2006 Jun;4(6):1323-30. doi: 10.1111/j.1538-7836.2006.01968.x.
6
Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII.与外周单核细胞结合的截短且无微粒的可溶性组织因子优先激活因子VII。
Thromb Haemost. 2006 Mar;95(3):462-8. doi: 10.1160/TH05-06-0432.
7
Initiation of coagulation by tissue factor carriers in blood.血液中组织因子载体引发的凝血过程。
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):188-90. doi: 10.1016/j.bcmd.2005.12.020. Epub 2006 Feb 13.
8
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.使用重组人凝血因子VIIa后的血栓栓塞不良事件。
JAMA. 2006 Jan 18;295(3):293-8. doi: 10.1001/jama.295.3.293.
9
Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.血浆组织因子加活化的外周血单个核细胞激活心脏手术伤口处的因子VII和因子X。
J Am Coll Cardiol. 2005 Aug 16;46(4):707-13. doi: 10.1016/j.jacc.2005.05.040.
10
Relevance of tissue factor in cardiovascular disease.组织因子在心血管疾病中的相关性。
Arch Mal Coeur Vaiss. 2005 Jun;98(6):667-71.
Zotero 插件